-
31 August 2022
New Report Recognizes Global Fund as Vital for Strong Global Health Results
One of the most rigorous reviews for multilateral organizations released an assessment today, announcing that the performance of the Global Fund to Fight AIDS, Tuberculosis and Malaria against 12 key performance indicators is satisfactory overall. -
27 August 2022
Global Fund Applauds Japan’s Major Commitment to Help End AIDS, Tuberculosis and Malaria and Strengthen Systems for Health
The Global Fund to Fight AIDS, Tuberculosis and Malaria praises Japan for its outstanding leadership in global health with a strong commitment of up to US$1.08 billion to help end the three diseases by 2030 and build stronger and more resilient and s... -
22 August 2022
Global Fund Approves Emergency Funding to Maintain Essential HIV Services in Sri Lanka
The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$989,687 in emergency funding to cover the gap of urgently needed health commodities for the treatment and prevention of HIV, including antiretrovirals, rapid tests, viral load te... -
08 August 2022
Catalytic Investment to Improve Community Health Care for Millions Across Africa
Today the Global Fund to Fight AIDS, TB and Malaria is announcing a crucial new catalytic fund to support community health workers across up to 10 African countries. The Africa Frontline First Catalytic Fund (AFF-CF) will provide financing to acceler... -
31 July 2022
Global Fund Reports Significant Progress in Breaking Down Human Rights-Related Barriers to HIV and TB Services
-
29 July 2022
As Progress Against HIV Slows, Global Fund Calls for Accelerated Investments in Innovations
The Global Fund to Fight AIDS, Tuberculosis and Malaria is deeply concerned about the slowdown of the global fight against HIV. A new UNAIDS report released this week at the International AIDS Conference in Montreal shows that progress against the di... -
23 June 2022
Global Fund Applauds Goodbye Malaria’s Contribution to Seventh Replenishment
The Global Fund welcomes Goodbye Malaria’s renewed commitment to the fight against AIDS, tuberculosis (TB) and malaria with a new pledge of US$5.5 million (ZAR 88 million) for the Global Fund’s Seventh Replenishment. -
31 May 2022
Luxembourg Increases Pledge by 30% for Global Fund’s Seventh Replenishment
The Global Fund to Fight AIDS, Tuberculosis and Malaria warmly welcomes today's announcement by Luxembourg of a €11.7 million pledge for the upcoming three-year period, a 30% increase in Luxembourg’s contributions to the Global Fund from the previous... -
24 May 2022
Global Fund and Partners Urge Increased Investment Towards Ending World’s Deadliest Diseases, Welcome First Private Sector Pledge
Ahead of the Global Fund’s Seventh Replenishment Conference, the Global Fund and partners called on all players in the private sector – philanthropists, foundations, and corporations – for a step-change in their commitment to ending AIDS, tuberculosi... -
20 May 2022
Global Fund Signs Letter of Intent with Pfizer for Oral COVID-19 Treatment
The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023.